Form 4: Arbutus Biopharma Director Reports Stock Transaction
Insider Transaction (Form 4)
Robert A Beardsley, a Director of Arbutus Biopharma Corp, reported a transaction in 17,948 shares of common stock on October 1, 2026.
Summary
- Disposition to the issuer: disposed of 17,948 Common Shares at $5.00 ($89,740) on October 1, 2026; holds 14,328 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Robert A Beardsley — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Disposition to the issuer | Common Shares | 17,948 | $5 | $89.7K | 14,328 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Disposition to the issuer (17,948 shares) |
Keywords
insider transaction, Form 4, ABUS, Arbutus Biopharma Corp, neutral, Robert A Beardsley
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.